Acuta Capital Partners’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.42M | Sell |
1,014,940
-204,784
| -17% | -$1.9M | 13.15% | 1 |
|
|
2025
Q1 | $8.94M | Buy |
1,219,724
+108,653
| +10% | +$796K | 10.37% | 1 |
|
|
2024
Q4 | $9.49M | Sell |
1,111,071
-79,000
| -7% | -$675K | 9.55% | 1 |
|
|
2024
Q3 | $10.4M | Sell |
1,190,071
-1,581,059
| -57% | -$13.8M | 8.39% | 2 |
|
|
2024
Q2 | $19M | Buy |
2,771,130
+135,843
| +5% | +$929K | 15.96% | 1 |
|
|
2024
Q1 | $24M | Buy |
2,635,287
+1,325,287
| +101% | +$12.1M | 15.58% | 1 |
|
|
2023
Q4 | $5.84M | Buy |
+1,310,000
| New | +$5.84M | 3.29% | 13 |
|
|
2022
Q3 | – | Sell |
-13,171
| Closed | -$53K | – | 52 |
|
|
2022
Q2 | $53K | Buy |
+13,171
| New | +$53K | 0.03% | 40 |
|